Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:36 UTC |
---|
HMDB ID | HMDB0000197 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Indoleacetic acid |
---|
Description | Indoleacetic acid (IAA) is a breakdown product of tryptophan metabolism and is often produced by the action of bacteria in the mammalian gut. Higher levels of IAA are associated with bacteria from Clostridium species including C. stricklandii, C. lituseburense, C. subterminale, and C. putrefaciens (PMID: 12173102 ). IAA can be found in Agrobacterium, Azospirillum, Bacillus, Bradyrhizobium, Clostridium, Enterobacter, Pantoea, Pseudomonas, Rhizobium (PMID: 12173102 , PMID: 17555270 , PMID: 12147474 , PMID: 19400643 , PMID: 9450337 , PMID: 21397014 ) (https://link.springer.com/chapter/10.1007/978-1-4612-3084-7_7) (https://escholarship.org/uc/item/1bf1b5m3). Some endogenous production of IAA in mammalian tissues also occurs. It may be produced by the decarboxylation of tryptamine or the oxidative deamination of tryptophan. IAA frequently occurs at low levels in urine and has been found in elevated levels in the urine of patients with phenylketonuria (PMID: 13610897 ). IAA has also been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821 ). Using material extracted from human urine, it was discovered by Kogl in 1933 that indoleacetic acid is also an important plant hormone (PMID: 13610897 ). Specifically, IAA is a member of the group of phytohormones called auxins. IAA is generally considered to be the most important native auxin. Plant cells synthesize IAA from tryptophan (Wikipedia ). IAA and some derivatives can be oxidized by horseradish peroxidase (HRP) into cytotoxic species. IAA is only toxic after oxidative decarboxylation; the effect of IAA/HRP is thought to be due in part to the formation of methylene-oxindole, which may conjugate with DNA bases and protein thiols. IAA/HRP could be used as the basis for targeted cancer, a potential new role for plant auxins in cancer therapy (PMID: 11163327 ). |
---|
Structure | InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13) |
---|
Synonyms | Value | Source |
---|
(indol-3-yl)Acetate | ChEBI | (indol-3-yl)Acetic acid | ChEBI | 2-(indol-3-yl)Ethanoic acid | ChEBI | 3-Indolylessigsaeure | ChEBI | Heteroauxin | ChEBI | IAA | ChEBI | IES | ChEBI | Indole-3-acetic acid | Kegg | Indoleacetate | Kegg | (1H-indol-3-yl)Acetate | Kegg | 2-(indol-3-yl)Ethanoate | Generator | Indole-3-acetate | Generator | (1H-indol-3-yl)Acetic acid | Generator | (1H-indol-3-yl)-Acetate | HMDB | (1H-indol-3-yl)-Acetic acid | HMDB | 1H-indol-3-Ylacetate | HMDB | 1H-indol-3-Ylacetic acid | HMDB | 1H-Indole-3-acetate | HMDB | 1H-Indole-3-acetic acid | HMDB | 2-(1H-indol-3-yl)Acetate | HMDB | 2-(1H-indol-3-yl)Acetic acid | HMDB | 2-(3-Indolyl)acetate | HMDB | 2-(3-Indolyl)acetic acid | HMDB | 3-(Carboxymethyl)indole | HMDB | 3-IAA | HMDB | 3-Indole-acetic acid | HMDB | 3-Indoleacetate | HMDB | 3-Indoleacetic acid | HMDB | 3-Indolylacetate | HMDB | 3-Indolylacetic acid | HMDB | alpha-indol-3-yl-Acetic acid | HMDB | b-Indoleacetate | HMDB | b-Indoleacetic acid | HMDB | b-Indolylacetate | HMDB | b-Indolylacetic acid | HMDB | beta-Indole-3-acetic acid | HMDB | beta-Indoleacetate | HMDB | beta-Indoleacetic acid | HMDB | beta-Indolylacetate | HMDB | beta-Indolylacetic acid | HMDB | indol-3-Ylacetate | HMDB | indol-3-Ylacetic acid | HMDB | Indolyl-3-acetate | HMDB | Indolyl-3-acetic acid | HMDB | Indolylacetate | HMDB | Indolylacetic acid | HMDB | Kyselina 3-indolyloctova | HMDB | Rhizopin | HMDB | Rhizopon a | HMDB | Skatole carboxylate | HMDB | Skatole carboxylic acid | HMDB | Indoleacetic acid, calcium salt | HMDB | Indoleacetic acid, monopotassium salt | HMDB | Indoleacetic acid, monosodium salt | HMDB | IES CPD | HMDB | Indole acetic acid | HMDB | Indoleacetic acid, alpha-(14)C-labeled | HMDB | (R,R)-3,3'-Dithiobis(2-aminopropanoic acid) | HMDB | (R-(R*,r*))-3,3'-dithiobis(2-aminopropanoic acid) | HMDB | 3,3'-Dithiobis-L-alanine | HMDB | beta,Beta'-diamino-beta,beta'-dicarboxydiethyl disulfide | HMDB | beta,Beta'-dithiodialanine | HMDB | Bis(beta-amino-beta-carboxyethyl) disulfide | HMDB | e921 | HMDB | L-alpha-Diamino-beta-dithiolactic acid | HMDB | L-Dicysteine | HMDB | Oxidized L-cysteine | HMDB | (R,R)-3,3'-Dithiobis(2-aminopropanoate) | HMDB | (R-(R*,r*))-3,3'-dithiobis(2-aminopropanoate) | HMDB | b,Beta'-diamino-b,beta'-dicarboxydiethyl disulfide | HMDB | b,Beta'-diamino-b,beta'-dicarboxydiethyl disulphide | HMDB | beta,Beta'-diamino-beta,beta'-dicarboxydiethyl disulphide | HMDB | Β,beta'-diamino-β,beta'-dicarboxydiethyl disulfide | HMDB | Β,beta'-diamino-β,beta'-dicarboxydiethyl disulphide | HMDB | b,Beta'-dithiodialanine | HMDB | Β,beta'-dithiodialanine | HMDB | Bis(b-amino-b-carboxyethyl) disulfide | HMDB | Bis(b-amino-b-carboxyethyl) disulphide | HMDB | Bis(beta-amino-beta-carboxyethyl) disulphide | HMDB | Bis(β-amino-β-carboxyethyl) disulfide | HMDB | Bis(β-amino-β-carboxyethyl) disulphide | HMDB | L-a-Diamino-b-dithiolactate | HMDB | L-a-Diamino-b-dithiolactic acid | HMDB | L-alpha-Diamino-beta-dithiolactate | HMDB | L-Α-diamino-β-dithiolactate | HMDB | L-Α-diamino-β-dithiolactic acid | HMDB | (-)-Cystine | HMDB | (R-(R*,r*))-3,3'-dithiobis | HMDB | 2-Amino-3-(2-amino-2-carboxy-ethyl)disulfanyl-propanoate | HMDB | 2-Amino-3-(2-amino-2-carboxy-ethyl)disulfanyl-propanoic acid | HMDB | 2-Amino-3-[(2-amino-2-carboxyethyl)dithio]propanoate | HMDB | 2-Amino-3-[(2-amino-2-carboxyethyl)dithio]propanoic acid | HMDB | 3,3'-Dithiobis | HMDB | 3,3'-Dithiobis[2-amino-[R-(r*,r*)]-propanoate | HMDB | 3,3'-Dithiobis[2-amino-[R-(r*,r*)]-propanoic acid | HMDB | 3,3'-Dithiodialanine | HMDB | b,B'-diamino-b,b'-dicarboxydiethyl disulfide | HMDB | b,B'-dithiodialanine | HMDB | beta,Beta'-dithiobisalanine | HMDB | Bis(b-amino-beta-carboxyethyl) disulfide | HMDB | Cysteine disulfide | HMDB | Cystin | HMDB | Cystine | HMDB | Cystine acid | HMDB | D(+)-3,3'-Dithiobis(2-aminopropanoate | HMDB | D(+)-3,3'-Dithiobis(2-aminopropanoic acid | HMDB | Dicysteine | HMDB | Gelucystine | HMDB | L-(-)-Cystine | HMDB | L-Cysteine disulfide | HMDB | L-Cystin | HMDB | [R-(R*,r*)]-3,3'-dithiobis | HMDB | L Cystine | HMDB | Copper cystinate | HMDB | (+)-Lactic acid | HMDB | (S)-(+)-Lactic acid | HMDB | (S)-2-Hydroxypropanoic acid | HMDB | (S)-2-Hydroxypropionic acid | HMDB | L-(+)-alpha-Hydroxypropionic acid | HMDB | L-(+)-Lactic acid | HMDB | L-Milchsaeure | HMDB | L-Lactate | HMDB | (+)-Lactate | HMDB | (S)-(+)-Lactate | HMDB | (S)-2-Hydroxypropanoate | HMDB | (S)-2-Hydroxypropionate | HMDB | L-(+)-a-Hydroxypropionate | HMDB | L-(+)-a-Hydroxypropionic acid | HMDB | L-(+)-alpha-Hydroxypropionate | HMDB | L-(+)-Α-hydroxypropionate | HMDB | L-(+)-Α-hydroxypropionic acid | HMDB | L-(+)-Lactate | HMDB | (alpha)-Lactate | HMDB | (alpha)-Lactic acid | HMDB | (S)-(+)-2-Hydroxypropanoate | HMDB | (S)-(+)-2-Hydroxypropanoic acid | HMDB | (S)-2-Hydroxy-propanoate | HMDB | (S)-2-Hydroxy-propanoic acid | HMDB | (S)-Lactate | HMDB | (S)-Lactic acid | HMDB | 1-Hydroxyethane 1-carboxylate | HMDB | 1-Hydroxyethane 1-carboxylic acid | HMDB | 1-Hydroxyethanecarboxylate | HMDB | 1-Hydroxyethanecarboxylic acid | HMDB | 2-Hydroxypropanoate | HMDB | 2-Hydroxypropanoic acid | HMDB | 2-Hydroxypropionate | HMDB | a-Hydroxypropanoate | HMDB | a-Hydroxypropanoic acid | HMDB | a-Hydroxypropionate | HMDB | a-Hydroxypropionic acid | HMDB | alpha-Hydroxypropanoate | HMDB | alpha-Hydroxypropanoic acid | HMDB | alpha-Hydroxypropionate | HMDB | alpha-Hydroxypropionic acid | HMDB | L-(+)- Lactic acid | HMDB | L-2-Hydroxypropanoate | HMDB | L-2-Hydroxypropanoic acid | HMDB | Lactate | HMDB | Lactic acid | HMDB | Milk acid | HMDB | Sarcolactic acid | HMDB | 2-Hydroxypropionic acid | HMDB | D-Lactic acid | HMDB | D Lactic acid | HMDB | Lactate, ammonium | HMDB | 2 Hydroxypropanoic acid | HMDB | 2 Hydroxypropionic acid | HMDB | Ammonium lactate | HMDB | L Lactic acid | HMDB | 9-beta-D-Ribofuranosyl-9H-purin-6-ol | HMDB | 9-beta-D-Ribofuranosylhypoxanthine | HMDB | Hypoxanthine D-riboside | HMDB | Hypoxanthosine | HMDB | i | HMDB | Inosin | HMDB | Inosina | HMDB | Inosinum | HMDB | Inotin | HMDB | 9-b-D-Ribofuranosyl-9H-purin-6-ol | HMDB | 9-Β-D-ribofuranosyl-9H-purin-6-ol | HMDB | 9-b-D-Ribofuranosylhypoxanthine | HMDB | 9-Β-D-ribofuranosylhypoxanthine | HMDB | (-)-Inosine | HMDB | 1,9-Dihydro-9-b-D-ribofuranosyl-6H-purin-6-one | HMDB | 1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one | HMDB | 1,9-Dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one | HMDB | 9-b-D-Ribofuranosyl-hypoxanthine | HMDB | 9-beta-D-Ribofuranosyl-hypoxanthine | HMDB | 9-beta-delta-Ribofuranosyl-hypoxanthine | HMDB | 9-beta-delta-Ribofuranosylhypoxanthine | HMDB | 9beta-D-Ribofuranosylhypoxanthine | HMDB | 9beta-delta-Ribofuranosylhypoxanthine | HMDB | Atorel | HMDB | beta-D-Ribofuranoside hypoxanthine-9 | HMDB | beta-delta-Ribofuranoside hypoxanthine-9 | HMDB | beta-Inosine | HMDB | HXR | HMDB | Hypoxanthine 9-beta-D-ribofuranoside | HMDB | Hypoxanthine 9-beta-delta-ribofuranoside | HMDB | Hypoxanthine nucleoside | HMDB | Hypoxanthine ribonucleoside | HMDB | Hypoxanthine riboside | HMDB | Hypoxanthine-9 beta-D-ribofuranoside | HMDB | Hypoxanthine-9 beta-delta-ribofuranoside | HMDB | Hypoxanthine-9-beta-D-ribofuranoside | HMDB | Hypoxanthine-9-beta-delta-ribofuranoside | HMDB | Hypoxanthine-9-D-ribofuranoside | HMDB | Hypoxanthine-9-delta-ribofuranoside | HMDB | Hypoxanthine-ribose | HMDB | Indole-3-carboxaldehyde | HMDB | Ino | HMDB | Inosie | HMDB | Iso-prinosine | HMDB | Oxiamin | HMDB | Panholic-L | HMDB | Pantholic-L | HMDB | Ribonosine | HMDB | Selfer | HMDB | Trophicardyl | HMDB | (2S)-6-(Acetylamino)-2-aminohexanoic acid | HMDB | N(6)-ACETYLLYSINE | HMDB | N(zeta)-Acetyllysine | HMDB | N-epsilon-Acetyl-L-lysine | HMDB | N-Epsilon-Acetyllysine | HMDB | N(epsilon)-Acetyl-L-lysine | HMDB | N(zeta)-Acetyl-L-lysine | HMDB | (2S)-6-(Acetylamino)-2-aminohexanoate | HMDB | N(Z)-Acetyllysine | HMDB | N(Ζ)-acetyllysine | HMDB | N(Z)-Acetyl-L-lysine | HMDB | N(Ζ)-acetyl-L-lysine | HMDB | e-Acetyl-L-lysine | HMDB | e-N-Acetyl-L-lysine | HMDB | e-N-Acetyllysine | HMDB | epsilon-Acetyl-L-lysine | HMDB | epsilon-N-Acetyl-L-lysine | HMDB | epsilon-N-Acetyllysine | HMDB | L-e-N-Acetyllysine | HMDB | L-epsilon-N-Acetyllysine | HMDB | N-e-Acetyl-L-lysine | HMDB | N-e-Acetyllysine | HMDB | N6-Acetyllysine | HMDB | Ne-acetyl-L-lysine | HMDB | Ne-acetyllysine | HMDB | Omega-N-acetyl-L-lysine | HMDB | W-N-Acetyl-L-lysine | HMDB | N(6)-Acetyllsine | HMDB | Omega-acetyllsine | HMDB | beta-Alanyl-3-methyl-L-histidine | HMDB | beta-Alanyl-N(pai)-methyl-L-histidine | HMDB | b-Alanyl-3-methyl-L-histidine | HMDB | Β-alanyl-3-methyl-L-histidine | HMDB | b-Alanyl-N(pai)-methyl-L-histidine | HMDB | Β-alanyl-N(pai)-methyl-L-histidine | HMDB | L-Anserine | HMDB | L-N-b-Alanyl-3-methyl-histidine | HMDB | L-N-beta-Alanyl-3-methyl-histidine | HMDB | N-b-Alanyl-3-methyl-L-histidine | HMDB | N-beta-Alanyl-3-methyl-L-histidine | HMDB | Balanine | HMDB | Beta Alanyl 3 methylhistidine | HMDB | Beta-Alanyl-3-methylhistidine | HMDB | Ophidine | HMDB | Indoleacetic acid | ChEBI | 3-(Carboxymethyl)-1H-indole | PhytoBank | 3-Indolylmethylcarboxylic acid | PhytoBank | alpha-IAA | PhytoBank | α-IAA | PhytoBank | beta-IAA | PhytoBank | β-IAA | PhytoBank | β-Indoleacetic acid | PhytoBank |
|
---|
Chemical Formula | C10H9NO2 |
---|
Average Molecular Weight | 175.184 |
---|
Monoisotopic Molecular Weight | 175.063328537 |
---|
IUPAC Name | 2-(1H-indol-3-yl)acetic acid |
---|
Traditional Name | β-indole-3-acetic acid |
---|
CAS Registry Number | 87-51-4 |
---|
SMILES | OC(=O)CC1=CNC2=CC=CC=C12 |
---|
InChI Identifier | InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13) |
---|
InChI Key | SEOVTRFCIGRIMH-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as indole-3-acetic acid derivatives. Indole-3-acetic acid derivatives are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Indolyl carboxylic acids and derivatives |
---|
Direct Parent | Indole-3-acetic acid derivatives |
---|
Alternative Parents | |
---|
Substituents | - Indole-3-acetic acid derivative
- 3-alkylindole
- Indole
- Substituted pyrrole
- Benzenoid
- Heteroaromatic compound
- Pyrrole
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Carbonyl group
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 168.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1.5 mg/mL | Not Available | LogP | 1.41 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Indoleacetic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CC1=C[NH]C2=CC=CC=C12 | 1928.6 | Semi standard non polar | 33892256 | Indoleacetic acid,1TMS,isomer #2 | C[Si](C)(C)N1C=C(CC(=O)O)C2=CC=CC=C21 | 2016.4 | Semi standard non polar | 33892256 | Indoleacetic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CC1=CN([Si](C)(C)C)C2=CC=CC=C12 | 1966.0 | Semi standard non polar | 33892256 | Indoleacetic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CC1=CN([Si](C)(C)C)C2=CC=CC=C12 | 1933.4 | Standard non polar | 33892256 | Indoleacetic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CC1=CN([Si](C)(C)C)C2=CC=CC=C12 | 2138.9 | Standard polar | 33892256 | Indoleacetic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC1=C[NH]C2=CC=CC=C12 | 2189.1 | Semi standard non polar | 33892256 | Indoleacetic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=C(CC(=O)O)C2=CC=CC=C21 | 2270.7 | Semi standard non polar | 33892256 | Indoleacetic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC=C12 | 2415.3 | Semi standard non polar | 33892256 | Indoleacetic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC=C12 | 2359.3 | Standard non polar | 33892256 | Indoleacetic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC=C12 | 2374.4 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0udi-0391000000-7581f14fe5be5b2b2954 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0udi-0691000000-de9ac4f748d50db109ea | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0udi-0591000000-9687f83d1372abe23c3c | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0udi-1793100000-7c78003038436ec5a902 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (1 TMS) | splash10-00ai-7910000000-4aa7b8244f32048c76bc | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0fk9-9250000000-a5f931fc3292056dba65 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-MS (1 TMS) | splash10-001i-1920000000-f0ecee61454a589493af | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-MS (2 TMS) | splash10-0udi-1692000000-ce863a1ca2a657cb41d5 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid EI-B (Non-derivatized) | splash10-003r-0900000000-1edcb4977a52155bc130 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Non-derivatized) | splash10-0udi-0391000000-7581f14fe5be5b2b2954 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Non-derivatized) | splash10-0udi-0691000000-de9ac4f748d50db109ea | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Non-derivatized) | splash10-0udi-0591000000-9687f83d1372abe23c3c | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Non-derivatized) | splash10-0udi-1793100000-7c78003038436ec5a902 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Non-derivatized) | splash10-00ai-7910000000-4aa7b8244f32048c76bc | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Non-derivatized) | splash10-0fk9-9250000000-a5f931fc3292056dba65 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-MS (Non-derivatized) | splash10-001i-1920000000-f0ecee61454a589493af | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-MS (Non-derivatized) | splash10-0udi-1692000000-ce863a1ca2a657cb41d5 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Indoleacetic acid GC-EI-TOF (Non-derivatized) | splash10-0udi-0691000000-f6073f8f35a6930b5aac | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Indoleacetic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0059-1900000000-ab74ec83b16ac0b97d12 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Indoleacetic acid GC-MS (1 TMS) - 70eV, Positive | splash10-001i-7920000000-8dab2ad22251c9fbd21c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Indoleacetic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Indoleacetic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Indoleacetic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Indoleacetic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Indoleacetic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-001i-1900000000-3ffc47eb6c977956ad93 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-004i-0900000000-f6dbb01a35af3042d126 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-004i-0900000000-2ae231b7d0e2cd50aed8 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-004i-6900000000-9eae14faa16b8f8259da | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid EI-B (HITACHI M-80) , Positive-QTOF | splash10-003r-0900000000-1edcb4977a52155bc130 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-00e9-0900000000-187b48f2258823cbc6a2 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-001i-0900000000-30b7a73fa446d0e3c8d3 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-004i-0900000000-bbe0fb5a48f89ea6e383 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-004i-0900000000-97850f400d80de278334 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-004i-0900000000-600545759ef108827b9e | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-0kxr-5900000000-ba2eed29832f9ee48921 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-004l-5900000000-a0b30710f83e53b6f3db | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-001i-9500000000-146ac0a20f9d53e76291 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-053r-9600000000-d9258b3c6b5c6f748f6e | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-004i-9300000000-b59628beb41b424daf4a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QQ (UPLC Waters, Quattro Ultima Pt Micromass) , Positive-QTOF (Annotated) | splash10-004i-0900000000-755373c9248cfb6425fc | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-004i-0900000000-2b3df7a1dd85faea6705 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive-QTOF | splash10-003r-0900000000-9522ab089ab89b64f96a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Indoleacetic acid LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative-QTOF | splash10-001i-0900000000-b735e95cb23091491c2e | 2012-08-31 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indoleacetic acid 10V, Positive-QTOF | splash10-0a4i-0900000000-2a3dd24f136523e6ce1e | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indoleacetic acid 20V, Positive-QTOF | splash10-053r-0900000000-77436493836245345cb8 | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indoleacetic acid 40V, Positive-QTOF | splash10-00lr-1900000000-4e0b6f24d03c0b25800f | 2015-04-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indoleacetic acid 10V, Negative-QTOF | splash10-00e9-0900000000-1d045a56f3669a1c9391 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indoleacetic acid 20V, Negative-QTOF | splash10-05ai-0900000000-518778c36bacbf77b901 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indoleacetic acid 40V, Negative-QTOF | splash10-0a5c-3900000000-323fc64084836756be30 | 2015-04-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Indoleacetic acid 10V, Positive-QTOF | splash10-0a4i-0900000000-2a3dd24f136523e6ce1e | 2015-05-27 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | - Brain
- Fibroblasts
- Kidney
- Liver
- Placenta
- Platelet
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 2.85 +/- 1.71 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.100 +/- 0.100 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.05 (0.0-0.118) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.05 (0.0- 0.1) uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.03 (0.005 - 0.3) uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0359 +/- 0.0150 uM | Children (1-13 years old) | Male | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0280 +/- 0.0127 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.339 +/- 0.0743 uM | Infant (0-1 year old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0251 +/- 0.00211 uM | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.859 +/- 2.16 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 1.08 +/- 1.40 uM | Adult (>18 years old) | Female | Normal | | details | Saliva | Detected and Quantified | 0.151 +/- 0.478 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 3.14 +/- 3.16 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 10.213 +/- 8.547 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.03-1.95 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 0.22(0.06-1.18) umol/mmol creatinine | Newborn (0-30 days old) | Female | Normal | | details | Urine | Detected and Quantified | 0.28(0.02-1.98) umol/mmol creatinine | Newborn (0-30 days old) | Male | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 41.027 +/- 21.106 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 24.75 +/- 16.978 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 3.4 (1.8-6.2) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 2.0 +/- 1.0 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | Urine | Detected and Quantified | 0.944 (0.457-1.294) umol/mmol creatinine | Children (1-13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 1.5-2.8 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 5.2 (0.1-31.0) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 4.6 (0.1-5.7) umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 3.4 (1.3-12.3) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 2.8 (0.1-5.5) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 3.8 (1.1-8.4) umol/mmol creatinine | Adolescent (13-18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.5-2.6 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 5.6 (5.5 - 5.8) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 2.6(0.6-5.4) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 13.70 +/- 12.56 uM | Adult (>18 years old) | Both | uremia | | details | Blood | Detected and Quantified | 5 +/- 3.200 uM | Adult (>18 years old) | Both | Uremia | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0251 +/- 0.00240 uM | Not Specified | Not Specified | anorexia | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0315 +/- 0.00748 uM | Children (1-13 years old) | Both | autism | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0299 +/- 0.00280 uM | Not Specified | Not Specified | depressive | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0247 +/- 0.00360 uM | Not Specified | Not Specified | Mania | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0337 +/- 0.00457 uM | Not Specified | Not Specified | Retarded depression | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Cryptosporidium infection | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Children (1-13 years old) | Both | Enthesitis-related arthritis | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Tooth Decay | | details | Saliva | Detected and Quantified | 0.571 +/- 0.992 uM | Adult (>18 years old) | Both | Dental caries | | details | Urine | Detected and Quantified | 11.58 +/- 10.413 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 45.731 +/- 33.914 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 64.967 +/- 50.993 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Gastroesophageal reflux disease | | details | Urine | Detected and Quantified | 42.755 +/- 34.674 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 33.666 +/- 20.269 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Gastroesophageal reflux disease | | details | Urine | Detected and Quantified | 3.0 (2.5-6.8) umol/mmol creatinine | Adult (>18 years old) | Both | Irritable bowel syndrome (IBS) | | details | Urine | Detected and Quantified | 1.636-2.0930 umol/mmol creatinine | Children (1-13 years old) | Female | Tryptophanuria with dwarfism | | details | Urine | Detected and Quantified | 6.165 umol/mmol creatinine | Adult (>18 years old) | Female | Pregnancy | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Bladder cancer | | details | Urine | Detected and Quantified | 3.5 +/- 0.33 umol/mmol creatinine | Adult (>18 years old) | Both | Appendicitis | | details | Urine | Detected and Quantified | 3.1 +/- 0.14 umol/mmol creatinine | Adult (>18 years old) | Both | Appendicitis | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Uremia |
---|
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
- Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. [PubMed:12675874 ]
| Anorexia nervosa |
---|
- Anderson GM, Gerner RH, Cohen DJ, Fairbanks L: Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid. Biol Psychiatry. 1984 Oct;19(10):1427-35. [PubMed:6518200 ]
| Autism |
---|
- Anderson GM, Ross DL, Klykylo W, Feibel FC, Cohen DJ: Cerebrospinal fluid indoleacetic acid in autistic subjects. J Autism Dev Disord. 1988 Jun;18(2):259-62. [PubMed:3410814 ]
| Major depressive disorder |
---|
- Anderson GM, Gerner RH, Cohen DJ, Fairbanks L: Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indoleacetic acid in cerebrospinal fluid. Biol Psychiatry. 1984 Oct;19(10):1427-35. [PubMed:6518200 ]
| Colorectal cancer |
---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Tooth Decay |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Appendicitis |
---|
- Ilkhanizadeh B, Owji AA, Tavangar SM, Vasei M, Tabei SM: Spot urine 5-hydroxy indole acetic acid and acute appendicitis. Hepatogastroenterology. 2001 May-Jun;48(39):609-13. [PubMed:11462886 ]
| Irritable bowel syndrome |
---|
- Bearcroft CP, Perrett D, Farthing MJ: Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998 Jan;42(1):42-6. [PubMed:9505884 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
| Tryptophanuria with dwarfism |
---|
- TADA K, ITO H, WADA Y, ARAKAWA T: CONGENITAL TRYPTOPHANURIA WITH DWARFISM ("H" DISEASE-LIKE CLINICAL FEATURES WITHOUT INDICANURIA AND GENERALIZED AMINOACIDURIA):--A PROBABLY NEW INBORN ERROR OF TRYPTOPHAN METABOLISM. Tohoku J Exp Med. 1963 Jul 25;80:118-34. [PubMed:14055140 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB07950 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB030920 |
---|
KNApSAcK ID | C00000100 |
---|
Chemspider ID | 780 |
---|
KEGG Compound ID | C00954 |
---|
BioCyc ID | INDOLE_ACETATE_AUXIN |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Indole-3-acetic_acid |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 802 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 16411 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | IND3AC |
---|
MarkerDB ID | MDB00013422 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Snyder, H. R.; Pilgrim, Frederick J. Preparation of 3-indoleacetic acid; new synthesis of tryptophol. Journal of the American Chemical Society (1948), 70 3770-1. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6. [PubMed:8087979 ]
- Igari T, Tsuchizawa M, Shimamura T: Alteration of tryptophan metabolism in the synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Tohoku J Exp Med. 1987 Oct;153(2):79-86. [PubMed:3500530 ]
- Carpenter LL, Anderson GM, Siniscalchi JM, Chappell PB, Price LH: Acute changes in cerebrospinal fluid 5-HIAA following oral paroxetine challenge in healthy humans. Neuropsychopharmacology. 2003 Feb;28(2):339-47. [PubMed:12589387 ]
- Owens MJ, Nemeroff CB: Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem. 1994 Feb;40(2):288-95. [PubMed:7508830 ]
- Tu JB, Wong CY: Serotonin metabolism in normal and abnormal infants during the perinatal period. Biol Neonate. 1976;29(3-4):187-93. [PubMed:133735 ]
- Blennow K, Wallin A, Gottfries CG, Mansson JE, Svennerholm L: Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. J Neural Transm Park Dis Dement Sect. 1993;5(1):5-15. [PubMed:7679905 ]
- Morgan WW, Grant RW: Increased rate of disappearance of serum probenecid in barbital dependent rats. Eur J Pharmacol. 1976 Dec;40(2):349-57. [PubMed:1033074 ]
- Jellinger K, Riederer P: Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human postmortem material. J Neural Transm. 1977;41(4):275-86. [PubMed:925688 ]
- Sarrias MJ, Cabre P, Martinez E, Artigas F: Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. J Neurochem. 1990 Mar;54(3):783-6. [PubMed:1689378 ]
- Kema IP, Meijer WG, Meiborg G, Ooms B, Willemse PH, de Vries EG: Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection. Clin Chem. 2001 Oct;47(10):1811-20. [PubMed:11568091 ]
- Bai F, Jones DC, Lau SS, Monks TJ: Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase. Chem Res Toxicol. 2001 Jul;14(7):863-70. [PubMed:11453733 ]
- Ridges AP, Bishop FM, Lawton K, Goldberg IJ: Amine metabolism, thyroid function and response to clomipramine and maprotiline medication in depression. Postgrad Med J. 1980;56 Suppl 1:37-41. [PubMed:6156444 ]
- Raghuram TC, Krishnaswamy K: Serotonin metabolism is pellagra. Arch Neurol. 1975 Oct;32(10):708-10. [PubMed:1180737 ]
- Carling RS, Degg TJ, Allen KR, Bax ND, Barth JH: Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem. 2002 Nov;39(Pt 6):577-82. [PubMed:12564839 ]
- Taniguchi K, Okatani Y, Sagara Y: Serotonin metabolism in the fetus in preeclampsia. Asia Oceania J Obstet Gynaecol. 1994 Mar;20(1):77-86. [PubMed:7513511 ]
- Russo S, Boon JC, Kema IP, Willemse PH, den Boer JA, Korf J, de Vries EG: Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation. Psychosom Med. 2004 May-Jun;66(3):422-5. [PubMed:15184706 ]
- Igari T, Shimamura T: Serotonin metabolism and its enzymic activities in joint diseases. Clin Orthop Relat Res. 1979 Mar-Apr;(139):232-49. [PubMed:455840 ]
- Bearcroft CP, Perrett D, Farthing MJ: Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998 Jan;42(1):42-6. [PubMed:9505884 ]
- Ilkhanizadeh B, Owji AA, Tavangar SM, Vasei M, Tabei SM: Spot urine 5-hydroxy indole acetic acid and acute appendicitis. Hepatogastroenterology. 2001 May-Jun;48(39):609-13. [PubMed:11462886 ]
- Apak S, Kazez A, Ozel SK, Ustundag B, Akpolat N, Kizirgil A: Spot urine 5-hydroxyindoleacetic acid levels in the early diagnosis of acute appendicitis. J Pediatr Surg. 2005 Sep;40(9):1436-9. [PubMed:16150345 ]
- WEISSBACH H, KING W, SJOERDSMA A, UDENFRIEND S: Formation of indole-3-acetic acid and tryptamine in animals: a method for estimation of indole-3-acetic acid in tissues. J Biol Chem. 1959 Jan;234(1):81-6. [PubMed:13610897 ]
- Folkes LK, Wardman P: Oxidative activation of indole-3-acetic acids to cytotoxic species- a potential new role for plant auxins in cancer therapy. Biochem Pharmacol. 2001 Jan 15;61(2):129-36. [PubMed:11163327 ]
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
- Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A: Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 2002 Sep 1;35(Suppl 1):S6-S16. doi: 10.1086/341914. [PubMed:12173102 ]
- Idris EE, Iglesias DJ, Talon M, Borriss R: Tryptophan-dependent production of indole-3-acetic acid (IAA) affects level of plant growth promotion by Bacillus amyloliquefaciens FZB42. Mol Plant Microbe Interact. 2007 Jun;20(6):619-26. doi: 10.1094/MPMI-20-6-0619. [PubMed:17555270 ]
- Patten CL, Glick BR: Role of Pseudomonas putida indoleacetic acid in development of the host plant root system. Appl Environ Microbiol. 2002 Aug;68(8):3795-801. [PubMed:12147474 ]
- Barash I, Manulis-Sasson S: Recent evolution of bacterial pathogens: the gall-forming Pantoea agglomerans case. Annu Rev Phytopathol. 2009;47:133-52. doi: 10.1146/annurev-phyto-080508-081803. [PubMed:19400643 ]
- Glickmann E, Gardan L, Jacquet S, Hussain S, Elasri M, Petit A, Dessaux Y: Auxin production is a common feature of most pathovars of Pseudomonas syringae. Mol Plant Microbe Interact. 1998 Feb;11(2):156-62. doi: 10.1094/MPMI.1998.11.2.156. [PubMed:9450337 ]
- Kochar M, Upadhyay A, Srivastava S: Indole-3-acetic acid biosynthesis in the biocontrol strain Pseudomonas fluorescens Psd and plant growth regulation by hormone overexpression. Res Microbiol. 2011 May;162(4):426-35. doi: 10.1016/j.resmic.2011.03.006. Epub 2011 Mar 23. [PubMed:21397014 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|